Moreover, we also confirmed that cytoplasmic GPR30 translocation in CAFs mediated the cAMP/PKA/CREB/glycolytic axis to confer resistance to TAM in ERα+ breast cancer cells [6]. The gene discussed is ESR1; the disease is breast cancer.